Number | Cited Articles |
1 |
Annarosa Floreani, Filippo Navaglia, Erik Rosa Rizzotto, Daniela Basso, Maria Chiaramonte, Andrea Padoan, Ioannis Petridis, Nora Cazzagon, Roberto Testa, Maurizio Marra, Mario Plebani. Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. Clinical Chemistry and Laboratory Medicine 2011; 49(2) doi: 10.1515/CCLM.2011.055
|
2 |
EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease. Journal of Hepatology 2012; 57(2): 399 doi: 10.1016/j.jhep.2012.04.004
|
3 |
Katarzyna Sikorska, Tomasz Romanowski, Piotr Stalke, Ewa Iżycka-Świeszewska, Krzysztof Piotr Bielawski. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis. Hepatobiliary & Pancreatic Diseases International 2011; 10(3): 270 doi: 10.1016/S1499-3872(11)60045-3
|
4 |
Albert J. Czaja. Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications. Alimentary Pharmacology & Therapeutics 2019; 49(6): 681 doi: 10.1111/apt.15173
|
5 |
Kaushik Kar, Anindya Dasgupta, M. Vijaya Bhaskar, K. Sudhakar. Alteration of Micronutrient Status in Compensated and Decompensated Liver Cirrhosis. Indian Journal of Clinical Biochemistry 2014; 29(2): 232 doi: 10.1007/s12291-013-0349-5
|
6 |
D. Robert Dufour. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 2012; : 1637 doi: 10.1016/B978-1-4160-6164-9.00050-0
|
7 |
B. Dervieux, J.C. Weber, M. Rondeau-Lutz, C. Martinez. Hyperferritinémie en consultation de médecine interne. La Revue de Médecine Interne 2015; 36: A33 doi: 10.1016/j.revmed.2015.03.256
|
8 |
Agustin Castiella, Eva Zapata, Maria Dolores De Juan, Pedro Otazua, Javier Fernandez, Leire Zubiaurre, Jose A. Arriola. Significance of H63D homozygosity in a Basque population with hemochromatosis. Journal of Gastroenterology and Hepatology 2010; 25(7): 1295 doi: 10.1111/j.1440-1746.2010.06247.x
|
9 |
Mark Thursz, Antoni Gual, Caroline Lackner, Philippe Mathurin, Christophe Moreno, Laurent Spahr, Martina Sterneck, Helena Cortez-Pinto. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. Journal of Hepatology 2018; 69(1): 154 doi: 10.1016/j.jhep.2018.03.018
|
10 |
Luís COSTA-MATOS, Paulo BATISTA, Nuno MONTEIRO, Pedro HENRIQUES, Fernando GIRÃO, Armando CARVALHO. HFE MUTATIONS AND IRON OVERLOAD IN PATIENTS WITH ALCOHOLIC LIVER DISEASE. Arquivos de Gastroenterologia 2013; 50(1): 35 doi: 10.1590/S0004-28032013000100008
|
11 |
Jonathan R Potts, Sumita Verma. Alcoholic hepatitis: diagnosis and management in 2012. Expert Review of Gastroenterology & Hepatology 2012; 6(6): 695 doi: 10.1586/egh.12.57
|
12 |
Dietmar Enko, Michael Novy, Christian Oberkanins, Gernot Kriegshäuser. Reverse-hybridization resolves a rare HFE genotype untypable by real-time PCR and melting curve analysis in a patient with hyperferritinemia and alcoholic liver disease. Clinical Chemistry and Laboratory Medicine (CCLM) 2019; 57(9): e234 doi: 10.1515/cclm-2018-1260
|
13 |
Katarzyna Sikorska, Agnieszka Bernat, Anna Wróblewska. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis. Hepatobiliary & Pancreatic Diseases International 2016; 15(5): 461 doi: 10.1016/S1499-3872(16)60135-2
|
14 |
Yan-yan Xu, Yu-han Tang, Xiao-ping Guo, Jing Wang, Ping Yao. HFE genetic variability and risk of alcoholic liver disease: A meta-analysis. Journal of Huazhong University of Science and Technology [Medical Sciences] 2016; 36(5): 626 doi: 10.1007/s11596-016-1637-0
|